Rivastigmine
NDC 70710-1196, Rivastigmine, patch, extended release, from Zydus Pharmaceuticals USA Inc..
- Product NDC
- 70710-1196
- Status
- Listed
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Dosage form
- PATCH, EXTENDED RELEASE
- Route
- TRANSDERMAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA206318
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1196 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RIVASTIGMINE4.6 mg/24h
Pharmacologic classes
Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70710-1196-7 | 70710119607 | 30 POUCH in 1 CARTON (70710-1196-7) / 24 h in 1 POUCH (70710-1196-1) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/64dad603-2389-456b-8c18-d1d40b7e7419NADAC price for package 70710119607
GET /v1/drugs/nadac/70710119607
Use it
Look up 70710-1196 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1196 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70710-1196. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.